Strs Ohio Makes New $1.43 Million Investment in DaVita Inc. $DVA

Key Points

• Strs Ohio has made a new investment of approximately $1.43 million in DaVita Inc., acquiring 9,340 shares in the first quarter, signaling confidence in the company's performance.
• DaVita reported earnings of $2.95 per share for the last quarter, exceeding expectations, and generated revenue of $3.38 billion, reflecting a year-over-year growth of 6.1%.
• Wall Street analysts have mixed views on DaVita's stock, with target prices ranging from $140 to $160 while the current consensus rating is "Reduce," indicating cautious sentiment among investors.

Strs Ohio acquired a new position in DaVita Inc. (NYSE:DVA - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 9,340 shares of the company's stock, valued at approximately $1,429,000.

A number of other hedge funds have also recently made changes to their positions in DVA. Ameriprise Financial Inc. boosted its stake in shares of DaVita by 27.2% in the fourth quarter. Ameriprise Financial Inc. now owns 32,545 shares of the company's stock worth $4,867,000 after acquiring an additional 6,951 shares during the period. ProShare Advisors LLC boosted its stake in shares of DaVita by 9.6% in the fourth quarter. ProShare Advisors LLC now owns 6,817 shares of the company's stock worth $1,019,000 after acquiring an additional 598 shares during the period. Rafferty Asset Management LLC boosted its stake in shares of DaVita by 9.4% in the fourth quarter. Rafferty Asset Management LLC now owns 5,118 shares of the company's stock worth $765,000 after acquiring an additional 438 shares during the period. State of Wyoming boosted its stake in DaVita by 59.6% during the fourth quarter. State of Wyoming now owns 2,020 shares of the company's stock valued at $302,000 after buying an additional 754 shares during the last quarter. Finally, Tidal Investments LLC boosted its stake in DaVita by 119.2% during the fourth quarter. Tidal Investments LLC now owns 12,466 shares of the company's stock valued at $1,864,000 after buying an additional 6,778 shares during the last quarter. Institutional investors own 90.12% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on DVA. Bank of America dropped their price target on DaVita from $145.00 to $140.00 and set an "underperform" rating for the company in a research note on Wednesday, September 10th. Barclays dropped their price target on DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Truist Financial set a $148.00 price target on DaVita in a research note on Friday, August 8th. Finally, Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research note on Saturday, September 13th. Three equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, DaVita has a consensus rating of "Reduce" and a consensus target price of $158.00.

Insider Buying and Selling at DaVita

In other news, insider James O. Hearty sold 2,351 shares of the stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the sale, the insider directly owned 26,038 shares in the company, valued at approximately $3,905,700. This represents a 8.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.50% of the company's stock.

DaVita Trading Down 0.2%

Shares of NYSE DVA traded down $0.29 during midday trading on Friday, hitting $129.94. The company's stock had a trading volume of 3,137,230 shares, compared to its average volume of 831,815. The company has a current ratio of 1.39, a quick ratio of 1.34 and a debt-to-equity ratio of 23.18. The business's 50 day moving average is $137.15 and its two-hundred day moving average is $141.02. DaVita Inc. has a 12-month low of $126.07 and a 12-month high of $179.60. The firm has a market cap of $9.29 billion, a P/E ratio of 12.78, a price-to-earnings-growth ratio of 0.93 and a beta of 1.13.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The firm had revenue of $3.38 billion for the quarter, compared to the consensus estimate of $3.36 billion. During the same period in the prior year, the business posted $2.00 earnings per share. The company's revenue for the quarter was up 6.1% on a year-over-year basis. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, equities research analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.